Nanobac Net Income vs Depreciation Analysis
| NNBP Stock | USD 0.0001 0.00 0.00% |
Nanobac Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Nanobac Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nanobac Pharmaceuticals is a good investment. Please check the relationship between Nanobac Pharmaceuticals Net Income and its Depreciation accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanobac Pharmaceuticals Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Net Income vs Depreciation
Net Income vs Depreciation Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nanobac Pharmaceuticals Net Income account and Depreciation. At this time, the significance of the direction appears to have pay attention.
The correlation between Nanobac Pharmaceuticals' Net Income and Depreciation is -0.73. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Depreciation in the same time period over historical financial statements of Nanobac Pharmaceuticals Incorporated, assuming nothing else is changed. The correlation between historical values of Nanobac Pharmaceuticals' Net Income and Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of Nanobac Pharmaceuticals Incorporated are associated (or correlated) with its Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation has no effect on the direction of Net Income i.e., Nanobac Pharmaceuticals' Net Income and Depreciation go up and down completely randomly.
Correlation Coefficient | -0.73 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Nanobac Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Nanobac Pharmaceuticals Incorporated operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Depreciation
Depreciation indicates how much of Nanobac Pharmaceuticals value has been used up. For tax purposes Nanobac Pharmaceuticals can deduct the cost of the tangible assets it purchases as business expenses. However, Nanobac Pharmaceuticals Incorporated must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Most indicators from Nanobac Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nanobac Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanobac Pharmaceuticals Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. As of 12/02/2024, Selling General Administrative is likely to drop to about 2.6 M. In addition to that, Discontinued Operations is likely to drop to about (54.1 K)
| 2010 | 2011 | 2023 | 2024 (projected) | Gross Profit | 8K | 3.1K | 3.6K | 3.4K | Total Revenue | 12K | 17.6K | 15.9K | 15.1K |
Nanobac Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Nanobac Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Additional Tools for Nanobac Stock Analysis
When running Nanobac Pharmaceuticals' price analysis, check to measure Nanobac Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobac Pharmaceuticals is operating at the current time. Most of Nanobac Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Nanobac Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobac Pharmaceuticals' price. Additionally, you may evaluate how the addition of Nanobac Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.